|1.||Tsai, Eing-Mei: 1 article (12/2014)|
|2.||Hou, Ming-Feng: 1 article (12/2014)|
|3.||Hung, Jen-Yu: 1 article (12/2014)|
|4.||Wang, Tsu-Nai: 1 article (12/2014)|
|5.||Hsu, Ya-Ling: 1 article (12/2014)|
|6.||Kuo, Po-Lin: 1 article (12/2014)|
|7.||Zhong, Zhiying: 1 article (12/2014)|
|8.||Tang, Yu: 1 article (12/2014)|
|9.||Gong, Yan: 1 article (12/2014)|
|10.||He, Shouzhi: 1 article (12/2014)|
12/01/2014 - "Obtusifolin administration for the entire duration of diabetes inhibited capillary cell apoptosis and the number of acellular capillaries in the retina, despite similar severity of hyperglycemia in the four diabetic groups (with and without obtusifolin). "
12/01/2014 - "The aim of this study was to evaluate the possible protective effects of obtusifolin against oxidative damage in diabetic hyperlipidemia and hyperglycemia. "
12/01/2014 - "Obtusifolin treatment improves hyperlipidemia and hyperglycemia: possible mechanism involving oxidative stress."
|4.||Neuralgia (Stump Neuralgia)
01/01/2014 - "Our results demonstrate that obtusifolin and gluco-obtusifolin produce significant antinociceptive action in rodent behavioral models of inflammatory/neuropathic pain, and that this activity is associated with modulation of neuroinflammation in spinal cord."
01/01/2014 - "Anti-allodynic effects of obtusifolin and gluco-obtusifolin against inflammatory and neuropathic pain."
01/01/2014 - "Chronic constriction injury (CCI), L5 spinal nerve ligation (L5 SNL), diabetes, and chemotherapeutics inducing allodynia were used to test whether repeated treatment with obtusifolin and gluco-obtusifolin ameliorated neuropathic pain. "
|5.||Neoplasm Metastasis (Metastasis)
|3.||Parathyroid Hormone-Related Protein
|5.||DNA (Deoxyribonucleic Acid)
|6.||phthalic acid (phthalate)